Text to be removed highlighted in red.
215:1 Glucagon Administration. Amend the section heading of RSA 200:40-b to read as follows:
200:40-b Glucagon Injections .
215:2 New Subparagraph; Controlled Drug Prescription Health and Safety Program; Dispenser Report. Amend RSA 126-A:91, VI by inserting after subparagraph (o) the following new subparagraph:
(p) The format of the prescription: electronic, faxed, written, oral, or other.
215:3 Effective Date.
I. Section 1 of this act shall take effect 60 days after its passage.
II. The remainder of this act shall take effect upon its passage.
Approved: June 17, 2022
Effective Date:
I. Section 1 effective August 16, 2022
II. Remainder effective June 17, 2022
Text to be added highlighted in green.
215:1 Glucagon Administration. Amend the section heading of RSA 200:40-b to read as follows:
200:40-b Glucagon Administration .
215:2 New Subparagraph; Controlled Drug Prescription Health and Safety Program; Dispenser Report. Amend RSA 126-A:91, VI by inserting after subparagraph (o) the following new subparagraph:
(p) The format of the prescription: electronic, faxed, written, oral, or other.
215:3 Effective Date.
I. Section 1 of this act shall take effect 60 days after its passage.
II. The remainder of this act shall take effect upon its passage.
Approved: June 17, 2022
Effective Date:
I. Section 1 effective August 16, 2022
II. Remainder effective June 17, 2022